Abstract

A group of 4-(3-(1-methoxycarbonyl-1,6-dihydropyridyl))- derivatives of alkyl 1,4-dihydro-2,6- dimethyl-3-nitro-5-pyridinecarboxylates 8a-e were synthesized by the regioselective reduction of the corresponding 4-(3-pyridyl)- analogs in the presence of methyl chloroformate using Li(t- BuO)3AlH. Alternatively, a related group of 4-(3-(1-methoxycarbonyl-4-substituted-1,4- dihydropyridyl))- compounds 14-18 were prepared using a modified Hantzsch reaction involving the condensation of 1-methoxycarbonyl-4-substituted-1,4-dihydropyridyl-3-carboxaldehydes 11a-c with an alkyl 3-aminocrotonate 12 and nitroacetone 13. In contrast to the 4-(3-pyridyl)- compound 2b, which exhibits an undesirable calcium channel agonist smooth muscle

Highlights

  • The design of cardioselective Hantzsch 1,4-dihydropyridine (DHP) L-type voltage sensitive calcium channel (CC) agonist positive inotropes has presented a significant challenge to medicinal chemistrs.[1,2,3]

  • The prototype 1,4-DHP CC agonist (S)-(+)-Bay K 8644 1 simultaneously promotes calcium entry into vascular smooth muscle, inducing vasconstriction, that prevents its clinical use for the treatment of congestive heart failure (CHF).[4,5]

  • Subsequent nuclear Overhauser enhancement (NOE) studies for compounds 4-5 indicated that there is a significant rotamer fraction in solution where the pyridyl nitrogen is oriented above the 1,4-DHP ring, irrespective of whether a substituent (Me, Ph) is located at the 6- (R1) or 3-position (R2) of the pyridyl ring

Read more

Summary

Introduction

The design of cardioselective Hantzsch 1,4-dihydropyridine (DHP) L-type voltage sensitive calcium channel (CC) agonist positive inotropes has presented a significant challenge to medicinal chemistrs.[1,2,3] the prototype 1,4-DHP CC agonist (S)-(+)-Bay K 8644 1 simultaneously promotes calcium entry into vascular smooth muscle, inducing vasconstriction, that prevents its clinical use for the treatment of congestive heart failure (CHF).[4,5] Recently, we discovered a novel third generation class of isomeric isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro4-(pyridyl)-5-pyridinecarboxylates 2a-c with different CC modulation activities.[6].

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.